PUBLISHER: The Business Research Company | PRODUCT CODE: 1751081
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751081
Preterm birth prevention and management encompasses a variety of strategies aimed at reducing the risk of early delivery, defined as birth before 37 weeks of gestation, and addressing complications related to premature birth. These strategies involve interventions both during pregnancy and after birth to ensure the health and safety of both the mother and baby.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The main categories of products for preterm birth prevention and management include pharmaceuticals, medical devices, and therapies. Pharmaceuticals refer to medicinal treatments used to prevent or manage preterm labor, such as progesterone supplements and tocolytics. These treatments are designed to address specific causes of preterm birth, including multiple pregnancies, infections, chronic conditions, structural abnormalities, and maternal lifestyle factors. Various diagnostic methods, such as ultrasound imaging, biochemical tests, and physical examinations, are used to identify these causes. The primary end users of these products include hospitals, clinics, homecare settings, and diagnostic laboratories.
The preterm birth prevention and management market research report is one of a series of new reports from The Business Research Company that provides preterm birth prevention and management market statistics, including preterm birth prevention and management industry global market size, regional shares, competitors with a preterm birth prevention and management market share, detailed preterm birth prevention and management market segments, market trends and opportunities, and any further data you may need to thrive in the preterm birth prevention and management industry. This preterm birth prevention and management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The preterm birth prevention and management market size has grown strongly in recent years. It will grow from$1.87 billion in 2024 to $2.01 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth during the historic period can be attributed to factors such as the rising incidence of preterm births, increasing maternal age, a surge in preterm complications, expanding awareness programs, and higher preterm mortality rates.
The preterm birth prevention and management market size is expected to see strong growth in the next few years. It will grow to$2.70 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to factors such as the rising demand for neonatal care, an increased focus on prevention, growing preconception counseling, expanding preterm birth screening programs, and heightened awareness among women. Key trends during this period include advancements in medical technologies, the integration of digital health, the development of AI-driven diagnostics, the creation of smart NICUs, and the incorporation of IoT in neonatal care.
The increasing awareness surrounding maternal and fetal health is expected to accelerate the growth of the preterm birth prevention and management market. Maternal and fetal health pertains to the well-being of pregnant women and their unborn children, aiming to ensure safe pregnancies and healthy outcomes. Public awareness of this issue is on the rise, driven by educational campaigns and awareness programs that emphasize the significance of prenatal care, proper nutrition, vaccinations, and regular screenings for healthier pregnancy results. Preventing and managing preterm births are crucial components of maternal and fetal health, as they help reduce complications such as respiratory distress, developmental delays in newborns, and maternal health risks linked to premature delivery. For example, in July 2024, the Welsh Government (Llywodraeth Cymru) reported that in 2023, the percentage of pregnant women with a BMI of 30 or higher at their initial assessment rose to 32%, a 0.8 percentage point increase from the previous year. This growing awareness is fueling the expansion of the preterm birth prevention and management market.
Leading companies in the preterm birth prevention and management market are launching initiatives, such as campaigns focused on combating preeclampsia and preterm birth, to raise awareness and enhance care for preterm infants. These campaigns aim to increase public knowledge, promote research, improve healthcare interventions, and advocate for policies that enhance maternal and neonatal health outcomes. For instance, in May 2024, March of Dimes Inc., a U.S.-based nonprofit organization, introduced the Low Dose, Big Benefits campaign. This long-term initiative seeks to reduce the risks of preeclampsia and preterm birth by promoting the use of low-dose aspirin. Preeclampsia, a severe pregnancy complication affecting 1 in 25 pregnancies, can be mitigated with low-dose aspirin, which reduces the risk by up to 15% for preeclampsia and 20% for preterm birth in high-risk pregnancies. The campaign addresses a critical knowledge gap, especially among Black families, who may be unaware of preeclampsia's risks.
In February 2024, Novocuff Inc., a U.S.-based medical device company, formed a partnership with Fogarty Innovation (FI) to enhance its efforts in preventing preterm births and improving pregnancy outcomes. The collaboration focuses on advancing Novocuff's cervical control device, designed to prevent preterm births. As part of this partnership, Novocuff received six months of mentorship through Fogarty's Company Accelerator Program to refine its technology and prepare for a major U.S. multi-center clinical trial in early 2025, with an eye toward global commercialization. Fogarty Innovation is a U.S.-based nonprofit incubator dedicated to advancing medical innovations that improve human health.
Major players in the preterm birth prevention and management market are Philips Healthcare, GE Healthcare Technologies Inc., NYU Langone Health, Penn Medicine, Sharp HealthCare, Hologic Inc., Duke University Health System, QIAGEN N.V., Ferring Pharmaceuticals, AMAG Pharmaceuticals, Miracle Babies, March of Dimes, Canberra Health Services, Perinatal Services BC, Natus Medical Incorporated, Society for Maternal-Fetal Medicine, DynaMed LLC, Sera Prognostics, Progenity Inc., and Birmingham Obstetrics & Gynecology.
North America was the largest region in the preterm birth prevention and management market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in preterm birth prevention and management report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the preterm birth prevention and management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The preterm birth prevention and management market includes revenues earned by entities by providing services such as prenatal screening and risk assessment, maternal health monitoring, pharmaceutical and therapeutic interventions, neonatal intensive care (NICU) services, and postnatal rehabilitation and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Preterm Birth Prevention And Management Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on preterm birth prevention and management market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for preterm birth prevention and management ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preterm birth prevention and management market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.